Dapagliflozin and Saxagliptin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dapagliflozin and Saxagliptin, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: FDA Approved: DAPAGLIFLOZIN AND SAXAGLIPTIN — Original Application (Novadoz Pharmaceuticals LLC)